World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 1, Number 6, December 2010, pages 236-241


A Case-Control Study of TP53 R72P Polymorphism in the Breast Cancer Patients of Ethnic Kashmiri Population

Tables

Table 1. Association Between TP53 Gene Codon 72 and Clinico-pathologic Characteristics
 
VariablesCases (n = 130)
Total
N = 130
RR
29 (22.3%)
R/P
37 (28.4%)
PP
64 (49.2%)
P Value; χ2
Dwelling
Rural:45 (34.6%)08 (17.77%)12 (26.66%)25 (55.55%)0.52 ; 1.27
Urban:85 (65.4%)21 (24.70%)25 (29.41%)29 (34.11%)
Smoking Status
Never:93 (71.5%)18 (19.35%)27 (29.03%)48 (51.61%)0.42 ; 1.69
Ever:37 (28.5%)11 (29.72%)10 (27.02%)16 (43.24%)
Menopausal Status
Pre:36 (27.7%)12 (33.33%)12 (33.33%)12 (33.33%)0.04 ; 6.16
Post:94 (72.3%)17 (18.08%)25 (26.59%)54 (57.44%)
Nodal Status
Involved34 (26.2%)12 (35.29%)09 (26.47%)13 (38.23%)0.09 ; 4.68
Not Involved96 (73.8%)17 (17.70%)28 (29.16%)51 (53.12%)
Tumor Stage
II(a+b)72 (55.4%)19 (26.38%)25 (34.72%)28 (38.88%)0.03 ; 6.93
III(a+b)+ IV58 (44.6%)10 (17.24%)12 (20.68%)36 (62.66%)
Histopathological Tumor
Grade
PD25 (19.23%)08 (32.0%)08 (32.0%)09 (36.0%)0.04 ; 6.21
MD + WD58 + 47 (80.76%)21 (20.0%)29 (27.61%)55 (52.38%)

 

Table 2. Genotype Frequencies of TP53 Gene Codon 72 Polymorphism in Cases and Controls and Their Associations With the Risk of Breast Cancer
 
TP53 R72P GenotypeCases (n = 130)Controls (n = 220)OR (95% CI ); p value
RR29 (22.31%)46 (20.91%)1 (Ref)
RP37 (28.46%)107 (48.64%)0.548 (0.30-0.99); 0.06
PP64 (49.23%)25 (11.36%)4.06 (2.10-7.82); 0.00002
RP+PP101 (77.69%)132 (60.0%)1.21 (0.71-2.06); 0.50